AdaptiveCME: Advances in Treatment to Improve the Quality of Life for Patients with Moderate-to-Severe Atopic Dermatitis
This activity is supported by an independent educational grant from Lilly.
Click Here to Manage Email Alerts
Overview
Release date: April 27, 2023
Expiration date: April 27, 2024
The estimated time to complete the activity is 60 minutes.
Provider Statement
This activity is jointly provided by Partners for Advancing Clinical Education and Catamount Medical Education.
Support Statement
This activity is supported by an independent educational grant from Lilly.
Target Audience
Clinicians who care for patients with moderate-to-severe atopic dermatitis, including dermatology and allergy nurse practitioners, physician assistants (PAs), physicians, and nurses.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Identify the quality of life (QOL) and disease impact of moderate-to-severe atopic dermatitis
- Evaluate evidence on the efficacy, safety, and impact on patients’ QOL of current and emerging targeted therapies for moderate-to-severe atopic dermatitis
- Apply patient-, disease-, and therapy-specific considerations in treatment decisions for patients with moderate-to-severe atopic dermatitis
Faculty
Jonathan I. Silverberg, MD, PHD, MPH
Professor
Director of Clinical Research
Director of Patch Testing
George Washington University School of Medicine and Health Sciences
Washington, DC
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and Catamount Medical Education. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.
Credit Designation
Physicians
PACE designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.00 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your certificate.
PA Continuing Medical Education
PACE has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid until April 27, 2024. PAs should only claim credit commensurate with the extent of their participation.
All other health care professionals completing this course will be issued a statement of participation.
How to Participate in this Activity and Obtain CE Credit
There are no fees for participating and receiving credit for this activity. During the period that the activity is available for credit, participants must:
1) Read the CE information
2) Complete the 10-question module
3) Complete the posttest and the evaluation form
A score of 80% correct must be achieved on the posttest to successfully complete the activity. If you do not receive a passing score, you will receive a message notifying you that you did not pass the posttest. You may retake the posttest until successful. Following the posttest and evaluation form your certificate will be made available immediately.
Faculty and Disclosure of Conflicts of Interest
Disclosure of Financial Relationships
PACE requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of an ineligible company.
Faculty Disclosures
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
Speakers Bureau: AbbVie, Alamar, Aldena, Amgen, Aobiome, Arcutis, Arena, Asana, Aslan, BioMX, Biosion, Bodewell, Boehringer-Ingelheim, Cara, Castle Biosciences, Celgene, Connect Biopharma, Dermavant, Dermira, Dermtech, Eli Lilly, Galderma, GlaxoSmithKline, Incyte Corporation, Kiniksa, Leo Pharma, Menlo, Novartis Pharmaceuticals Corporation, Pfizer, RAPT, Regeneron, Sanofi, Shaperon, Union
Susan Denner, MD, MS, Chief Medical Officer, Catamount Medical Education has no relevant financial relationships to report.
Alexa Lasek, Project Manager, Catamount Medical Education has no relevant financial relationships to report.
The PACE planners and others have no relevant financial relationship(s) to disclose with ineligible companies.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Contact Information
For questions about this activity, please contact Catamount Medical Education at: info@catmeded.com.
For additional information about the accreditation of this activity, please visit https://partnersed.com.